Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced on October 29, 2025, that it purchased 320,000 of its ordinary shares with a nominal value of 31¼ pence each on October 28, 2025. The shares were bought through BNP Paribas SA at prices ranging from 1,634.00p to 1,655.00p per share, with a volume-weighted average price of 1,644.29p. These shares will be held as treasury shares, forming part of the company's existing buyback program announced on September 30, 2025. Since that date, GSK has purchased 6,768,500 ordinary shares. Following this transaction, GSK holds 254,233,344 ordinary shares in treasury and has 4,061,187,442 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.26 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings